Technological Advancements in Prosthetics

Tuesday, March 6, 2012 - 6:30pm

Those that suffer the misfortune of becoming a limb amputee will have to endure the immense emotional and physical challenges associated with this radical change in lifestyle. Unfortunately, in many markets, both developed and developing, the individual may also face significant financial difficulties related to the reimbursement of the purchase of prostheses and its subsequent maintenance. Among developed nations, this problem is especially pronounced in the United States. The lack of public and private reimbursement options supporting the purchase of prosthetics often cause American patients to adopt less-than-ideal prosthetics or not adopt a prosthetic altogether. This is especially unfortunate because reimbursement options limit the patient’s ability to take advantage of the great technological progress made in this field. The severe financial caps, co-pays, and high deductibles often make the purchase of more advanced prosthetics prohibitively expensive. As a result, barring any significant changes in the reimbursement landscape, cheaper and more durable prosthetics will be necessary to address this patient-access dilemma.

This presentation will propose a U.S. launch strategy for a durable knee prosthetic, the LC Knee, currently in development at the Bloorview Research Institute. The presentation also serves to outline many of the characteristics and concerns inherent in the limb prosthetics market and how that relates to the adoption of innovative prosthetic devices.

Presented by Team Aithon.

Team Aithon

Tuesday, March 6, 2012, 6:30-7:30pm, Instructional Centre, Room 335. Also available via webcast. Open to the public.

The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar series.